Purchase Order W81K0217P0414
Award Date 10/1/17
Potential Completion Date 9/30/20
Potential Value $600K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portage, MI 49002, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide Phadia Allergy Testing Reagents to the Tripler Army Medical Center (TAMC) in Hawaii. The $546,082.44 contract has a completion date of September 30, 2023. Phadia has previously provided allergy testing analyzers, reagents, and associated consumables to Department of Defense health agencies and facilities to support military medical readiness....
- Phadia US Inc., a subsidiary of Thermo Fisher Scientific, was awarded a $596,483.76 firm fixed-price purchase order by the Defense Health Agency on October 1, 2023, to provide allergy testing analyzers and reagents for Tripler Army Medical Center in Hawaii. The contract represents Exercise Option II and includes notification of completion, with a completion date of September 30, 2026. The procurement was conducted using FAR Part 12 simplified acquisition procedures for commercial items, with...
- This is a $3,332,143.51 definitive, firm-fixed-price federal contract awarded by the Department of the Army Medical Command to Phadia US Inc. Immunodiagnostics Division, a subsidiary of Thermo Fisher Scientific. The contract is for the provision of allergy testing equipment, reagents, and associated consumables to support the military's medical readiness mission. Phadia has previously provided similar allergy testing products and services to other Department of Defense health agencies and...
- This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the delivery of $146,363.76 in allergen detection equipment and reagents. Phadia is a provider of allergy and autoimmune testing solutions, and has previously supplied allergy testing analyzers, reagents, and associated consumables to Department of Defense health agencies and facilities to support their medical readiness...
- This is a firm-fixed-price BPA call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for allergy and asthma testing products and services to support military medical readiness and research programs. Phadia has received multiple prime federal contracts from agencies such as the Defense Health Agency and Department of the Air Force for its proprietary IMMUNOCAP SYSTEM ANALYZERS and related...
- This is a federal contract award to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide reagents required for allergy testing. The contract is a Blanket Purchase Agreement (BPA) Call with the Defense Health Agency, a defense agency, with a ceiling value of $24,960.42 and a completion date of September 30, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in...
- This firm-fixed-price Blanket Purchase Agreement (BPA) call was awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific Inc. The contract has a ceiling value of $600,000.00 and no set-aside designation. It provides for the procurement of immunodiagnostic analyzers, reagents, and consumables used for allergen and asthma testing to support military medical readiness and research programs. This contract is part of a larger BPA awarded by...
- This is a firm-fixed-price contract awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the manufacture of in-vitro diagnostic substances. The $24,960.42 contract has a period of performance through September 30, 2025 and was awarded on June 17, 2025 without a set-aside designation. Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing IMMUNOCAP SYSTEM ANALYZERS and related equipment, software, supplies,...
- The Department of the Army Medical Command awarded a $892,500 firm fixed price purchase order to Phadia US Inc. Immunodiagnostics Division for autoimmune and allergy testing reagents with an analyzer. The prime contractor, Phadia US, is a division of Thermo Electron Corporation Financial Services. The contract has a period of performance from May 29, 2020 through May 31, 2025. The place of performance will be in Germany. This purchase order supports the Army Medical Command's mission to...
- This is a firm-fixed-price BPA call issued by the U.S. Army Medical Command (MEDCOM) in Germany for the month of December 2016, awarded to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for the procurement of Phadia's proprietary IMMUNOCAP SYSTEM ANALYZERS and related equipment, supplies, and technical support to support military medical readiness and research programs. Phadia has been the sole source provider for these types of allergy...